Histamine content in colorectal cancer. Are there sufficient levels of histamine to affect lymphocyte function?

被引:30
作者
Reynolds, JL [1 ]
Akhter, J [1 ]
Adams, WJ [1 ]
Morris, DL [1 ]
机构
[1] UNIV NSW, ST GEORGE HOSP, DEPT SURG, SYDNEY, NSW 2217, AUSTRALIA
来源
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY | 1997年 / 23卷 / 03期
关键词
histamine content; colon cancer; lymphocytes; cimetidine;
D O I
10.1016/S0748-7983(97)92388-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Histamine has been found to stimulate growth of colorectal cancer in vitro and in vivo. Histamine has also been found to inhibit lymphocyte activity in vitro at concentrations greater than 10(-7) M. The aim of our study was to determine if the histamine concentrations in human colorectal cancer mere sufficient to achieve these effects. We measured the histamine content in 31 colorectal cancer specimens using a radioenzymatic assay. Results were expressed as mu g histamine per gram of fresh tissue weight, Recovery and reproducibility studies were also carried out. The median histamine concentration in colorectal cancer tissue mas 8.4 mu g/g [7.6 x 10(-5) M], ranging from 0.3 mu g/g to 20.6 mu g/g. The high concentration of histamine in colon cancer is enough to be locally immunosuppressive.
引用
收藏
页码:224 / 227
页数:4
相关论文
共 26 条
[1]   SHORT-COURSE CIMETIDINE AND SURVIVAL WITH COLORECTAL-CANCER [J].
ADAMS, WJ ;
MORRIS, DL .
LANCET, 1994, 344 (8939-4) :1768-1769
[2]   CIMETIDINE INHIBITS IN-VIVO GROWTH OF HUMAN COLON-CANCER AND REVERSES HISTAMINE-STIMULATED IN-VITRO AND IN-VIVO GROWTH [J].
ADAMS, WJ ;
LAWSON, JA ;
MORRIS, DL .
GUT, 1994, 35 (11) :1632-1636
[3]  
BARTHOLEYNS J, 1984, CANCER RES, V44, P639
[4]  
BERMAN JS, 1984, J IMMUNOL, V133, P1495
[5]   CHEMOATTRACTANT LYMPHOKINES SPECIFIC FOR THE HELPER INDUCER LYMPHOCYTE-T SUBSET [J].
BERMAN, JS ;
CRUIKSHANK, WW ;
CENTER, DM ;
THEODORE, AC ;
BEER, DJ .
CELLULAR IMMUNOLOGY, 1985, 95 (01) :105-112
[6]   INCREASED TISSUE HISTAMINE IN TUMOR-BEARING MICE AND RATS [J].
BURTIN, C ;
SCHEINMANN, P ;
SALOMON, JC ;
LESPINATS, G ;
FRAYSSINET, C ;
LEBEL, B ;
CANU, P .
BRITISH JOURNAL OF CANCER, 1981, 43 (05) :684-688
[7]  
CHANDA R, 1998, CANC LETT, V34, P207
[8]   MAST-CELL MODULATION OF TUMOR-CELL PROLIFERATION IN RAT MAMMARY ADENOCARCINOMA-13762NF [J].
DABBOUS, MK ;
HANEY, L ;
NICOLSON, GL ;
ECKLEY, D ;
WOOLLEY, DE .
BRITISH JOURNAL OF CANCER, 1991, 63 (06) :873-878
[9]   PROGNOSTIC-SIGNIFICANCE OF EOSINOPHILS AND MAST-CELLS IN RECTAL-CANCER - FINDINGS FROM THE NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT (PROTOCOL R-01) [J].
FISHER, ER ;
PAIK, SM ;
ROCKETTE, H ;
JONES, J ;
CAPLAN, R ;
FISHER, B .
HUMAN PATHOLOGY, 1989, 20 (02) :159-163
[10]   COMPARISON BETWEEN NUMBER OF BASOPHILS, BLOOD HISTAMINE, AND HISTAMINE-RELEASE IN CANCER AND NONCANCER PATIENTS [J].
GALOPPIN, L ;
NOIROT, C ;
WASTIAUX, JP ;
SCHEINMANN, P ;
PAUPE, J ;
BURTIN, C .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1989, 84 (04) :501-506